检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:石文霞(综述)[1] 周红(审校)[1]
机构地区:[1]江苏大学基础医学与医学技术学院检验医学研究所,江苏镇江210001
出 处:《肿瘤研究与临床》2008年第9期646-648,共3页Cancer Research and Clinic
基 金:教育部回国人员科研启动基金(教外司[2003]406)
摘 要:蛋白酶激活受体-2(PAR-2)属于与G蛋白相耦联的受体家族,其N-末端被蛋白酶裂解后形成新的N-末端。新N-末端能够结合、激活受体自身。最新资料表明,PAR-2可表达于某些肿瘤组织及培养细胞,与肿瘤细胞的增生、侵袭与转移及血管生成等密切相关。Protease-activated receptor-2 (PAR-2) belongs to the receptor family which is coupled with G-protein. The N-terminus of PAR-2 is cleaved by some proteases to generate a new N-terminus. The new N-terminus can interact with and activate the receptor itself. The update research reported that PAR-2 could be expressed on some cancers as well as tumor cell lines. There are some relationships between the PAR-2 expression and the behaviors of tumor cell, such as proliferation, angiogenesis, migration and invasion.
分 类 号:R730.231.3[医药卫生—肿瘤]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:3.17.146.235